WaferGen Biosystems, Inc. (OTC BB: WGBS) is focused on developing, manufacturing and commercializing next-generation systems for gene expression, genotyping, stem cell research and cell biology for the life science and pharmaceutical industries. The company is developing what could become the platform of choice for genetic analysis as well as cell monitoring enabling genomics and cell biology from research to clinic. WaferGen’s innovative systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies. For further information, visit the Company’s web site at www.wafergen.com.
- 18 years ago
QualityStocks
WaferGen Biosystems, Inc. (OTC BB: WGBS)
Tags Rodman & Renshaw
Related Post
-
Greenland Mines Ltd. (NASDAQ: GRML) Advances World-Class Palladium Deposit with Major Resource Upgrade
The combination of a structurally concentrated supply base, rising geopolitical risk from the dominant Russian…
-
Regentis Biomaterials Ltd. (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3 Billion Cartilage Repair Market
Regentis is targeting an estimated $3 billion U.S. cartilage repair market opportunity, supported by approximately…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Is Building a Modern Public Safety Platform by Integrating Tools, Training and Policy
Wrap Technologies treats non-lethal response as a system rather than a single device, integrating tools,…